Phenanthriplatin
Phenanthriplatin or cis-[Pt(NH3)2-(phenanthridine)Cl]NO3 is a new drug candidate. It belongs to a family of platinum(II)-based agents which includes cisplatin, oxaliplatin and carboplatin. Phenanthriplatin was discovered by Professor Stephen J. Lippard at Massachusetts Institute of Technology and is currently being developed by Blend Therapeutics for its potential use in human cancer therapy.
primaryTopic
Phenanthriplatin
Phenanthriplatin or cis-[Pt(NH3)2-(phenanthridine)Cl]NO3 is a new drug candidate. It belongs to a family of platinum(II)-based agents which includes cisplatin, oxaliplatin and carboplatin. Phenanthriplatin was discovered by Professor Stephen J. Lippard at Massachusetts Institute of Technology and is currently being developed by Blend Therapeutics for its potential use in human cancer therapy.
has abstract
Phenanthriplatin or cis-[Pt(NH ...... l use in human cancer therapy.
@en
ATC prefix
CAS number
1416900-51-0
IUPAC name
cis-[Pt(NH3)2-(phenanthridine)Cl]NO3
@en
thumbnail
Wikipage page ID
41,698,280
Wikipage revision ID
728,511,926
molecular weight
subject
hypernym
comment
Phenanthriplatin or cis-[Pt(NH ...... l use in human cancer therapy.
@en
label
Phenanthriplatin
@en